Decatur Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-52,728
Closed -$3.52M 66
2021
Q2
$3.52M Buy
52,728
+84
+0.2% +$5.48K 1.1% 28
2021
Q1
$3.32M Sell
52,644
-47,338
-47% -$2.95M 1.15% 29
2020
Q4
$6.2M Sell
99,982
-2,175
-2% -$134K 1.14% 32
2020
Q3
$6.16M Buy
102,157
+19,101
+23% +$1.15M 1.21% 31
2020
Q2
$4.88M Buy
83,056
+2
+0% +$120 1.29% 28
2020
Q1
$4.63M Sell
83,054
-21,311
-20% -$1.3M 1.55% 18
2019
Q4
$6.7M Sell
104,365
-1,338
-1% -$76.6K 1.53% 20
2019
Q3
$5.36M Sell
105,703
-41,025
-28% -$1.93M 1.32% 35
2019
Q2
$6.65M Sell
146,728
-3,325
-2% -$155K 1.25% 38
2019
Q1
$7.16M Buy
150,053
+18
+0% +$897 1.38% 36
2018
Q4
$7.8M Buy
150,035
+28,100
+23% +$1.51M 1.75% 23
2018
Q3
$7.57M Sell
121,935
-30,300
-20% -$1.8M 1.74% 24
2018
Q2
$8.43M Sell
152,235
-925
-0.6% -$50K 1.67% 26
2018
Q1
$9.69M Sell
153,160
-4,540
-3% -$292K 2% 21
2017
Q4
$9.66M Sell
157,700
-24,775
-14% -$1.55M 1.96% 25
2017
Q3
$11.6M Buy
182,475
+10,550
+6% +$616K 2.23% 14
2017
Q2
$9.58M Buy
+171,925
New +$9.36M 2.01% 24

Other funds holding BMY

Decatur Capital Management's BMY Position: Q3 2021 in Review

Decatur Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 52,728 shares — an estimated $3.52M sold.

Decatur Capital Management first reported a position in BMY in Q2 2017 and held it in 17 quarters. The position peaked at $11.6M in Q3 2017. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Decatur Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
  • Decatur Capital Management sold 52,728 Bristol-Myers Squibb shares in Q3 2021, an estimated $3.52M.
  • Decatur Capital Management first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 17 quarters.
  • Decatur Capital Management's Bristol-Myers Squibb position peaked at $11.6M in Q3 2017.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Decatur Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.